Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction. / Jabbari, Reza; Risgaard, Bjarke; Fosbøl, Emil Loldrup; Scheike, Thomas; Philbert, Berit Thornvig; Winkel, Bo Gregers; Albert, Christine M.; Glinge, Charlotte; Ahtarovski, Kiril A.; Haunso, Stig; Køber, Lars Valeur; Jørgensen, Erik; Pedersen, Frants; Tfelt-Hansen, Jacob; Engstrøm, Thomas.

In: American Journal of Cardiology, Vol. 116, No. 5, 01.09.2015, p. 678-685.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Jabbari, R, Risgaard, B, Fosbøl, EL, Scheike, T, Philbert, BT, Winkel, BG, Albert, CM, Glinge, C, Ahtarovski, KA, Haunso, S, Køber, LV, Jørgensen, E, Pedersen, F, Tfelt-Hansen, J & Engstrøm, T 2015, 'Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction', American Journal of Cardiology, vol. 116, no. 5, pp. 678-685. https://doi.org/10.1016/j.amjcard.2015.05.037

APA

Jabbari, R., Risgaard, B., Fosbøl, E. L., Scheike, T., Philbert, B. T., Winkel, B. G., Albert, C. M., Glinge, C., Ahtarovski, K. A., Haunso, S., Køber, L. V., Jørgensen, E., Pedersen, F., Tfelt-Hansen, J., & Engstrøm, T. (2015). Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction. American Journal of Cardiology, 116(5), 678-685. https://doi.org/10.1016/j.amjcard.2015.05.037

Vancouver

Jabbari R, Risgaard B, Fosbøl EL, Scheike T, Philbert BT, Winkel BG et al. Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction. American Journal of Cardiology. 2015 Sep 1;116(5):678-685. https://doi.org/10.1016/j.amjcard.2015.05.037

Author

Jabbari, Reza ; Risgaard, Bjarke ; Fosbøl, Emil Loldrup ; Scheike, Thomas ; Philbert, Berit Thornvig ; Winkel, Bo Gregers ; Albert, Christine M. ; Glinge, Charlotte ; Ahtarovski, Kiril A. ; Haunso, Stig ; Køber, Lars Valeur ; Jørgensen, Erik ; Pedersen, Frants ; Tfelt-Hansen, Jacob ; Engstrøm, Thomas. / Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction. In: American Journal of Cardiology. 2015 ; Vol. 116, No. 5. pp. 678-685.

Bibtex

@article{d1aa746c41f349de8913863a332cace9,
title = "Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction",
abstract = " We aimed to assess the risk factors and outcome of ventricular fibrillation (VF) before and duringprimary percutaneous coronary intervention (PPCI) in patients with ST-segment elevationmyocardial infarction. From 1999 to 2012, we consecutively enrolled 5,373 patients withST-segment elevation myocardial infarction. In total, 410 of the patients had VF before and 88had VF during PPCI. During a mean follow-up of 4.2 years, 1,196 subjects died. A logisticregression model identified younger age, anterior infarct, Killip class >I at admission, and apreprocedural Thrombolysis In Myocardial Infarction flow grade of 0 to I to be significantlyassociated with VF before PPCI, whereas inferior infarct, a preprocedural Thrombolysis InMyocardial Infarction flow grade of 0 to I, and Killip class >I at admission were significantlyassociated with VF during PPCI. All-cause mortality was evaluated using the Cox regressionmodel. Compared with the patients without VF, those with VF before or during PPCI had asignificantly increased 30-day mortality, with an adjusted hazard ratio [ 3.40 (95% confidenceinterval 1.70 to 6.70) and 4.20 (95% confidence interval 1.30 to 13.30), respectively. Importantly,there was no tendency of 30-day mortality difference between VF before and during PPCI (p [0.170). In patients with VF before or during PPCI who survived for at least 30 days, there was noincrease in the long-term mortality. In conclusion, our data suggest that 30-day mortality is thesame for patients with VF before PPCI compared with VF during PPCI, and the occurrence of VFbefore or during PPCI was associated with increased 30-day mortality but not with long-termmortality.",
author = "Reza Jabbari and Bjarke Risgaard and Fosb{\o}l, {Emil Loldrup} and Thomas Scheike and Philbert, {Berit Thornvig} and Winkel, {Bo Gregers} and Albert, {Christine M.} and Charlotte Glinge and Ahtarovski, {Kiril A.} and Stig Haunso and K{\o}ber, {Lars Valeur} and Erik J{\o}rgensen and Frants Pedersen and Jacob Tfelt-Hansen and Thomas Engstr{\o}m",
year = "2015",
month = sep,
day = "1",
doi = "10.1016/j.amjcard.2015.05.037",
language = "English",
volume = "116",
pages = "678--685",
journal = "Am. J. Cardiol.",
issn = "0002-9149",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction

AU - Jabbari, Reza

AU - Risgaard, Bjarke

AU - Fosbøl, Emil Loldrup

AU - Scheike, Thomas

AU - Philbert, Berit Thornvig

AU - Winkel, Bo Gregers

AU - Albert, Christine M.

AU - Glinge, Charlotte

AU - Ahtarovski, Kiril A.

AU - Haunso, Stig

AU - Køber, Lars Valeur

AU - Jørgensen, Erik

AU - Pedersen, Frants

AU - Tfelt-Hansen, Jacob

AU - Engstrøm, Thomas

PY - 2015/9/1

Y1 - 2015/9/1

N2 - We aimed to assess the risk factors and outcome of ventricular fibrillation (VF) before and duringprimary percutaneous coronary intervention (PPCI) in patients with ST-segment elevationmyocardial infarction. From 1999 to 2012, we consecutively enrolled 5,373 patients withST-segment elevation myocardial infarction. In total, 410 of the patients had VF before and 88had VF during PPCI. During a mean follow-up of 4.2 years, 1,196 subjects died. A logisticregression model identified younger age, anterior infarct, Killip class >I at admission, and apreprocedural Thrombolysis In Myocardial Infarction flow grade of 0 to I to be significantlyassociated with VF before PPCI, whereas inferior infarct, a preprocedural Thrombolysis InMyocardial Infarction flow grade of 0 to I, and Killip class >I at admission were significantlyassociated with VF during PPCI. All-cause mortality was evaluated using the Cox regressionmodel. Compared with the patients without VF, those with VF before or during PPCI had asignificantly increased 30-day mortality, with an adjusted hazard ratio [ 3.40 (95% confidenceinterval 1.70 to 6.70) and 4.20 (95% confidence interval 1.30 to 13.30), respectively. Importantly,there was no tendency of 30-day mortality difference between VF before and during PPCI (p [0.170). In patients with VF before or during PPCI who survived for at least 30 days, there was noincrease in the long-term mortality. In conclusion, our data suggest that 30-day mortality is thesame for patients with VF before PPCI compared with VF during PPCI, and the occurrence of VFbefore or during PPCI was associated with increased 30-day mortality but not with long-termmortality.

AB - We aimed to assess the risk factors and outcome of ventricular fibrillation (VF) before and duringprimary percutaneous coronary intervention (PPCI) in patients with ST-segment elevationmyocardial infarction. From 1999 to 2012, we consecutively enrolled 5,373 patients withST-segment elevation myocardial infarction. In total, 410 of the patients had VF before and 88had VF during PPCI. During a mean follow-up of 4.2 years, 1,196 subjects died. A logisticregression model identified younger age, anterior infarct, Killip class >I at admission, and apreprocedural Thrombolysis In Myocardial Infarction flow grade of 0 to I to be significantlyassociated with VF before PPCI, whereas inferior infarct, a preprocedural Thrombolysis InMyocardial Infarction flow grade of 0 to I, and Killip class >I at admission were significantlyassociated with VF during PPCI. All-cause mortality was evaluated using the Cox regressionmodel. Compared with the patients without VF, those with VF before or during PPCI had asignificantly increased 30-day mortality, with an adjusted hazard ratio [ 3.40 (95% confidenceinterval 1.70 to 6.70) and 4.20 (95% confidence interval 1.30 to 13.30), respectively. Importantly,there was no tendency of 30-day mortality difference between VF before and during PPCI (p [0.170). In patients with VF before or during PPCI who survived for at least 30 days, there was noincrease in the long-term mortality. In conclusion, our data suggest that 30-day mortality is thesame for patients with VF before PPCI compared with VF during PPCI, and the occurrence of VFbefore or during PPCI was associated with increased 30-day mortality but not with long-termmortality.

U2 - 10.1016/j.amjcard.2015.05.037

DO - 10.1016/j.amjcard.2015.05.037

M3 - Journal article

C2 - 26150175

VL - 116

SP - 678

EP - 685

JO - Am. J. Cardiol.

JF - Am. J. Cardiol.

SN - 0002-9149

IS - 5

ER -

ID: 160443147